glp 1 ckd Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Real-World Evidence for GLP-1 Receptor

The connections between metabolic health, inflammation, aging, and body composition are becoming clearer with each new study, and GLP-1 receptor agonists sit at the intersection of multiple research pathways

Constipation self-care

Sepsis-induced activation of endogenous GLP-1 system is enhanced in type 2 diabetes

When considering skeletal muscle mass, it's essential to recognize that muscle quantity does not necessarily equate to muscle quality

Normal cold sensitivity associated with weight loss during GLP-1 therapy typically presents as: A general feeling of being cooler than before treatment commenced Needing extra layers of clothing or preferring warmer environments Cold hands and feet, particularly in cool weather Symptoms that correlate with the amount of weight lost No other concerning features such as extreme fatigue, confusion, or changes in heart rate These sensations usually stabilise once weight loss plateaus and the body adjusts to its new composition

When a hexafluoroleucine was introduced at position 29 or 32, a moderate loss in binding affinity and biological activity was observed